Washington Capital Management’s Exact Sciences EXAS Stock Holding History

Washington Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-67,403	Closed	-$622K	–	134
2015 Q4	$622K	Sell	67,403 -492	-0.7%	-$4.58K	0.39%	87
2015 Q3	$1.22M	Buy	67,895 +2,083	+3%	+$47.8K	0.76%	68
2015 Q2	$1.96M	Buy	+65,812	New	+$1.65M	1.1%	33
2014 Q4	–	Sell	-24,464	Closed	-$474K	–	138
2014 Q3	$474K	Sell	24,464 -1,244	-5%	-$22.8K	0.19%	102
2014 Q2	$438K	Hold	25,708	–	–	0.16%	112
2014 Q1	$364K	Sell	25,708 -141,333	-85%	-$1.91M	0.13%	124
2013 Q4	$1.96M	Sell	167,041 -3,943	-2%	-$45.2K	0.47%	96
2013 Q3	$2.02M	Sell	170,984 -19,949	-10%	-$256K	0.54%	81
2013 Q2	$2.66M	Buy	+190,933	New	+$2.07M	0.69%	57

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Washington Capital Management's EXAS Position: Q1 2016 in Review

Washington Capital Management sold out of Exact Sciences (EXAS) in Q1 2016, closing a stake of 67,403 shares — an estimated $622K sold.

Washington Capital Management first reported a position in EXAS in Q2 2013 and held it in 9 quarters. The position peaked at $2.66M in Q2 2013. 167 funds tracked by Wall St. Rank hold EXAS as of Q1 2016.

Washington Capital Management reported no remaining Exact Sciences position as of Q1 2016 after selling out during the quarter.
Washington Capital Management sold 67,403 Exact Sciences shares in Q1 2016, an estimated $622K.
Washington Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 9 quarters.
Washington Capital Management's Exact Sciences position peaked at $2.66M in Q2 2013.
167 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2016.

Based on Washington Capital Management's 13F filing for Q1 2016, filed 9 May 2016.